Skip to main content

Advertisement

Log in

Experimental and Clinical Efficacy of Two Hyaluronic Acid-based Compounds of Different Cross-Linkage and Composition in the Rejuvenation of the Skin

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

ABSTRACT

Background

In the field of aesthetic medicine there is an increasing demand for safe and effective hyaluronic acid (HA) fillers to counteract the aging process.

Methods and Aims

We designed a study to evaluate the safety and histological biocompatibility of Aliaxin® Global Performance, a cross-linked HA filler and Viscoderm® Skinkò E, a product composed of non-cross-linked HA and a complex including vitamins, antioxidants, amino acids and minerals injected into the skin of guinea pigs. Then, we translated our findings into the clinical setting, administering a combination of these compounds to patients seeking a facial rejuvenation procedure targeting moderate-to-severe wrinkles affecting the nasolabial folds.

Results

The animal study showed that the two compounds did not induce any significant inflammatory reactions and increased collagen and elastic fibers in the skin. In the clinical setting, injection of Aliaxin® Global Performance, followed by Viscoderm® Skinkò E, resulted in a higher improvement in nasolabial fold hydration, trans-epidermal water loss and wrinkle aesthetic appearance, if compared with a protocol based on Aliaxin® Global Performance alone.

Conclusion

In summary, we show evidence on the safety and mechanism underlying two new HA-based compounds of different cross-linkage and composition, proposing that they can be safely used in combination in patients seeking facial rejuvenation procedures with long-lasting efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

Aliaxin® GP:

Aliaxin® Global Performance

BDDE:

1,4-Butanediol diglycidyl ether

CLHA:

Cross-linked HA

HA:

Hyaluronic acid

HE:

Hematoxylin and eosin

HPF:

High-power field

N:

Newton

NCLHA:

Non-cross-linked HA

PBS:

Phosphate buffered saline

PWBC:

Polymorphonuclear white blood cells

SEM:

Standard error of the mean

TEWL:

Trans-epidermal water loss

TGF-β:

Transforming growth factor beta

Viscoderm® SE:

Viscoderm® Skinkò E

WSRS:

Wrinkle severity rating scale

REFERENCES

  1. Nemoto T, Kubota R, Murasawa Y, Isogai Z. Viscoelastic properties of the human dermis and other connective tissues and its relevance to tissue aging and aging–related disease, viscoelasticity - from theory to biological applications. In: De Vicente J, editor. ISBN: 978-953-51-0841-2, InTech. doi:10.5772/50146. 2012. Available from: http://wwwintechopencom/books/viscoelasticity-from-theory-to-biological-applications/viscoelastic-properties-of-the-human-dermis-and-other-connective-tissues-and-its-relevance-to-tissue.

  2. Agache P, Humbert P. Measuring the skin. Germany: Springer-Verlag Berlin Heidelberg; 2004.

    Book  Google Scholar 

  3. Fisher GJ, Varani J, Voorhees JJ. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol. 2008;144(5):666–72.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Varani J, Dame MK, Rittie L, Fligiel SE, Kang S, Fisher GJ, et al. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006;168(6):1861–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Iannitti T, Palmieri B. Inflammation and genetics: an insight in the centenarian model. Hum Biol. 2011;83(4):531–59.

    Article  PubMed  Google Scholar 

  6. Cohen JL, Dayan SH, Brandt FS, Nelson DB, Axford-Gatley RA, Theisen MJ, et al. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg Off Publ Am Soc Dermatol Surg [et al]. 2013;39(2):205–31.

    CAS  Google Scholar 

  7. Sood V, Nanda S. Patient Satisfaction with Hyaluronic Acid Fillers for Improvement of the Nasolabial Folds in Type IV & V Skin. J Maxillofac Oral Surg. 2012;11(1):78–81.

    Article  PubMed  Google Scholar 

  8. Cartier H, Trevidic P, Rzany B, Sattler G, Kestemont P, Kerrouche N, et al. Perioral rejuvenation with a range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips. J Drug Dermatol: JDD. 2012;11(1 Suppl):s17–26.

    CAS  Google Scholar 

  9. Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg. 2006;22(5):335–41. discussion 341–333.

    Article  PubMed  Google Scholar 

  10. Eccleston D, Murphy DK. Juvederm((R)) Volbella in the perioral area: a 12-month prospective, multicenter, open-label study. Clin Cosmet Investig Dermatol. 2012;5:167–72.

    PubMed  PubMed Central  Google Scholar 

  11. Beasley KL, Weiss MA, Weiss RA. Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg: FPS. 2009;25(2):86–94.

    Article  CAS  PubMed  Google Scholar 

  12. Iannitti T, Capone S, Palmieri B. Short review on face rejuvenation procedures: focus on preoperative antiseptic and anesthetic delivery by JetPeel-3 (a high pressure oxygen delivery device). Minerva Chir. 2011;66(3 Suppl 1):1–8.

    CAS  PubMed  Google Scholar 

  13. Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs. 1994;47(3):536–66.

    Article  CAS  PubMed  Google Scholar 

  14. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release: Off J Control Release Soc. 1998;53(1–3):93–103.

    Article  CAS  Google Scholar 

  15. Redbord KP, Busso M, Hanke CW. Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers. Dermatol Ther. 2011;24(1):71–81.

    Article  PubMed  Google Scholar 

  16. Iannitti T, Elhensheri M, Bingol AO, Palmieri B. Preliminary histopathological study of intra-articular injection of a novel highly cross-linked hyaluronic acid in a rabbit model of knee osteoarthritis. J Mol Histol. 2013;44(2):191–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Iannitti T, Lodi D, Palmieri B. Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid. Drug R&D. 2011;11(1):13–27.

    Article  Google Scholar 

  18. Iannitti T, Rottigni V, Palmieri B. A pilot study to compare two different hyaluronic acid compounds for treatment of knee osteoarthritis. Int J Immunopathol Pharmacol. 2012;25(4):1093–8.

    CAS  PubMed  Google Scholar 

  19. Palmieri B, Rottigni V, Iannitti T. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. Drug Des Dev Ther. 2013;7:7–12.

    CAS  Google Scholar 

  20. Littara A, Palmieri B, Rottigni V, Iannitti T. A clinical study to assess the effectiveness of a hyaluronic acid-based procedure for treatment of premature ejaculation. Int J Impot Res. 2013;25(3):117–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Iannitti T, Rottigni V, Torricelli F, Palmieri B. Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study. Clin Appl Thromb Hemost: Off J Int Acad Clin Appl Thromb/Hemost. 2014;20(3):326–30.

  22. Iannitti T, Bingol AO, Rottigni V, Palmieri B. Biocompatibility and rheological properties of a new highly viscoelastic hyaluronic acid in a rat model for biomaterial implants and first-in-man clinical investigation in esthetic and restorative medicine. Int J Pharm. 2013. doi:10.1016/j.ijpharm.2013.06.066.

    PubMed  Google Scholar 

  23. Ardizzoni A, Neglia RG, Baschieri MC, Cermelli C, Caratozzolo M, Righi E, et al. Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens. J Mater Sci Mater Med. 2011;22(10):2329–38.

    Article  CAS  PubMed  Google Scholar 

  24. Cermelli C, Cuoghi A, Scuri M, Bettua C, Neglia RG, Ardizzoni A, et al. In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. Virol J. 2011;8:141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Marusza W, Mlynarczyk G, Olszanski R, Netsvyetayeva I, Obrowski M, Iannitti T, et al. Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine. 2012;7:1441–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Arsiwala SZ. Safety and persistence of non-animal stabilized hyaluronic Acid fillers for nasolabial folds correction in 30 Indian patients. J Cutan Aesthet Surg. 2010;3(3):156–61.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Quan T, Wang F, Shao Y, Rittie L, Xia W, Orringer JS, et al. Enhancing structural support of the dermal microenvironment activates fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo. J Investig Dermatol. 2013;133(3):658–67.

    Article  CAS  PubMed  Google Scholar 

  28. Turlier V, Delalleau A, Casas C, Rouquier A, Bianchi P, Alvarez S, et al. Association between collagen production and mechanical stretching in dermal extracellular matrix: In vivo effect of cross-linked hyaluronic acid filler. A randomised, placebo-controlled study. J Dermatol Sci. 2013;69(3):187–94.

    Article  CAS  PubMed  Google Scholar 

  29. Day DJ, Littler CM, Swift RW, Gottlieb S. The wrinkle severity rating scale: a validation study. Am J Clin Dermatol. 2004;5(1):49–52.

    Article  PubMed  Google Scholar 

  30. Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain: Off J Am Pain Soc. 2003;4(7):407–14.

    Article  Google Scholar 

  31. Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg: Off Publ Am Soc Dermatol Surg [et al]. 1998;24(12):1317–25.

    Article  CAS  Google Scholar 

  32. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet Plast Surg. 2003;27(5):354–66. discussion 367.

    Article  Google Scholar 

  33. Niechajev I. Lip enhancement: surgical alternatives and histologic aspects. Plast Reconstr Surg. 2000;105(3):1173–83. discussion 1184–1177.

    Article  CAS  PubMed  Google Scholar 

  34. Ghislanzoni M, Bianchi F, Barbareschi M, Alessi E. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol. 2006;154(4):755–8.

    CAS  PubMed  Google Scholar 

  35. Lowe NJ, Maxwell CA, Lowe P, Duick MG, Shah K. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45(6):930–3.

    Article  CAS  PubMed  Google Scholar 

  36. Rongioletti F, Cattarini G, Sottofattori E, Rebora A. Granulomatous reaction after intradermal injections of hyaluronic acid gel. Arch Dermatol. 2003;139(6):815–16.

    Article  PubMed  Google Scholar 

  37. Micheels P. Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg Off Publ Am Soc Dermatol Surg [et al]. 2001;27(2):185–91.

    CAS  Google Scholar 

  38. Tung R, Ruiz de Luzuriaga AM, Park K, Sato M, Dubina M, Alam M. Brighter eyes: combined upper cheek and tear trough augmentation: a systematic approach utilizing two complementary hyaluronic acid fillers. J Drug Dermatol: JDD. 2012;11(9):1094–7.

    CAS  PubMed  Google Scholar 

  39. Iannitti T, Rottigni V, Palmieri B. Corticosteroid transdermal delivery to target swelling, edema and inflammation following facial rejuvenation procedures. Drug Des Dev Ther. 2013;7:1035–41.

    Article  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS AND DISCLOSURES

This article was not supported by grants. JCMM acknowledges CONACyT for membership.

TI, JCM, AC and BP contributed equally to every part of this work including design and conduction of clinical and experimental studies as well as statistical analysis and drafting of the article.

The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript. We thank IBSA Farmaceutici Italia for the donation of Viscoderm® Skinko’ E and Aliaxin® Global Performance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tommaso Iannitti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iannitti, T., Morales-Medina, J.C., Coacci, A. et al. Experimental and Clinical Efficacy of Two Hyaluronic Acid-based Compounds of Different Cross-Linkage and Composition in the Rejuvenation of the Skin. Pharm Res 33, 2879–2890 (2016). https://doi.org/10.1007/s11095-014-1354-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-014-1354-y

KEY WORDS

Navigation